Disability News and Research

RSS

Medications commonly prescribed for schizophrenia linked to cognitive impairment

Writing in the May 14, 2021 issue of The American Journal of Psychiatry, a multi-institution team of scientists led by researchers at University of California San Diego School of Medicine report that medications commonly prescribed to reduce the severity of physical and mental health symptoms associated with schizophrenia may have a cumulative effect of worsening cognitive function in patients.

18 May 2021

Delaying second dose of covid-19 vaccine could result in lower mortality under certain conditions

Delaying the second dose of covid-19 vaccines, at least for people aged under 65, could result in up to 20% lower mortality, but only under certain conditions, finds a US study published by The BMJ today.

17 May 2021

A leading group of scientists working in universities, research centres, and innovative companies across Belgium, Germany, Greece, Portugal, Spain, and Switzerland just initiated a groundbreaking project hoping to treat stroke once and for all. The project, given the code name “ANGIE”, is backed by EU funding. "European scientists started developin

17 May 2021

Scientists initiate a groundbreaking project to treat stroke once and for all

A leading group of scientists working in universities, research centers, and innovative companies across Belgium, Germany, Greece, Portugal, Spain, and Switzerland just initiated a groundbreaking project hoping to treat stroke once and for all.

17 May 2021

Simple sugar could play a key role in the development of progressive MS

Multiple sclerosis, or MS for short, manifests itself slightly differently in each person - which is why some call it "the disease of a thousand faces."

12 May 2021

Investment in primary prevention can reduce rheumatic heart disease in the African Union

Rheumatic heart disease (RHD) remains a major cause of cardiovascular disease in Africa, even as acute rheumatic fever and RHD have become rare in high-income countries.

12 May 2021

Covid-19 patients show reduced gray matter volume in the brain

Covid-19 patients who receive oxygen therapy or experience fever show reduced gray matter volume in the frontal-temporal network of the brain, according to a new study led by researchers at Georgia State University and the Georgia Institute of Technology.

12 May 2021

Chronic pain is becoming more common in the United States

Americans are in chronic pain, and a comprehensive new study exploring trends in this major public health concern reveals that what has been a long-standing and under-acknowledged problem is getting substantially worse.

12 May 2021

Spiritual fitness and meditative practice may reduce multiple risk factors for Alzheimer's disease

It is projected that up to 152 million people worldwide will be living with Alzheimer's disease (AD) by 2050. To date there are no drugs that have a substantial positive impact on either the prevention or reversal of cognitive decline.

11 May 2021

Combining two medications doubles gout treatment success, study reveals

By combining two medications, researchers at Michigan Medicine optimized a therapy for people with gout, a condition that causes severe damage and disability if left untreated.

11 May 2021

Damage to the white matter is more predictive of cognitive impairment after brain injury

A new University of Iowa study challenges the idea that gray matter (the neurons that form the cerebral cortex) is more important than white matter (the myelin covered axons that physically connect neuronal regions) when it comes to cognitive health and function.

7 May 2021

Researchers highlight the need for more reliable methods to predict risk of relapse into depression

At least half of patients recovering from depression will experience a relapse, but there are currently no evidence-based tools to help GPs or other healthcare professionals to identify those at high risk.

7 May 2021

New $10.7 million project aims to study the genetic underpinnings of Alzheimer's disease

Despite decades of research and investment, the genetic underpinnings of Alzheimer's disease are still largely unknown, stymieing drug development and early diagnosis efforts.

5 May 2021

Study investigates the level of knowledge of young people and adolescents on "zoonotic diseases"

The EU-funded BIO-CRIME project - with support from the Leibniz Institute for Zoo and Wildlife Research (Leibniz-IZW) - conducted a scientific investigation on the topic of illegal small animal trade and the associated risk of pathogen transmission.

5 May 2021

Biomedical engineer receives NIH Trailblazer grant to advance research on paralysis, brain damage

Imagine harnessing the proliferating power of cancer cells to treat spinal cord injuries and restore function following brain damage. It's an idea that University of Massachusetts Amherst biomedical engineer Chase Cornelison has been exploring in recent years.

5 May 2021

Study highlights mechanisms that explain the rise and fall in temporary disability rates

Working conditions, mass layoffs and other economy-related reasons could explain the rises and falls in temporary disability rates.

4 May 2021

$3.5 million grant awarded to address the underrepresentation of Black adults in Alzheimer's research

Black adults are more likely than other groups to develop Alzheimer's disease or related disorders but are poorly represented in Alzheimer's disease research, including recent clinical trials. This health disparity illustrates how Black individuals can benefit from advances in the field if they had access.

4 May 2021

Disability News and Research

Medications commonly prescribed for schizophrenia linked to cognitive impairment

Delaying second dose of covid-19 vaccine could result in lower mortality under certain conditions

Scientists initiate a groundbreaking project to treat stroke once and for all

Simple sugar could play a key role in the development of progressive MS

Investment in primary prevention can reduce rheumatic heart disease in the African Union

Covid-19 patients show reduced gray matter volume in the brain

Chronic pain is becoming more common in the United States

Spiritual fitness and meditative practice may reduce multiple risk factors for Alzheimer's disease

Combining two medications doubles gout treatment success, study reveals

Damage to the white matter is more predictive of cognitive impairment after brain injury

Researchers highlight the need for more reliable methods to predict risk of relapse into depression

New $10.7 million project aims to study the genetic underpinnings of Alzheimer's disease

Study investigates the level of knowledge of young people and adolescents on "zoonotic diseases"

Biomedical engineer receives NIH Trailblazer grant to advance research on paralysis, brain damage

Study highlights mechanisms that explain the rise and fall in temporary disability rates

$3.5 million grant awarded to address the underrepresentation of Black adults in Alzheimer's research

A new 3D model for myotonic dystrophy

Social cognition may exert a central role in the daily lives of MS patients

Scientists develop an ultrasonic imaging system to visualize cell abnormalities in 3D

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News